Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mightex is a private life science tools and photonics company that develops and commercializes optical stimulation, optogenetics, calcium imaging, and bioscience imaging systems for research use. Its product portfolio includes the OASIS in vivo imaging and stimulation platforms, Polygon patterned illumination systems, cameras, LED and laser light sources, spectrometers, controllers, and related software and fiber-optic components. The company serves academic and industrial researchers working in neuroscience, cell biology, photostimulation, and other bioscience applications rather than developing therapeutic drugs. Mightex also maintains a broader photonics and instrumentation business spanning industrial imaging, microscopy, spectroscopy, and OEM components. Overall, it is best characterized as a commercial bioscience tools company focused on enabling optical experiments and imaging workflows in life science research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mightex Systems.